bioAffinity Technologies (BIAF) Research & Development (2021 - 2026)
bioAffinity Technologies (BIAF) reported Research & Development of $349707.0 for Q1 2026, down 4.81% year-over-year from $367386.0 in Q1 2025, and down 6.5% quarter-over-quarter from $374012.0 in Q4 2025.
bioAffinity Technologies (BIAF) Research & Development (2021 - 2026) Analysis & Trends
bioAffinity Technologies (BIAF) has 6 years of Research & Development data on file, last reported at $349707.0 in Q1 2026.
- Research & Development for Q1 2026 came in at $349707.0, down 4.81% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.4 million (down 4.83% YoY), and the FY2025 annual result was $1.4 million, down 5.33% from the prior year.
- Research & Development slipped to $349707.0 in Q1 2026 per BIAF's latest filing, from $374012.0 in the prior quarter.
- Over five years, Research & Development peaked at $450612.0 in Q4 2022 and troughed at $248419.0 in Q2 2022.
- A 5-year average of $350638.4 and a median of $349707.0 in 2026 frame the typical range for Research & Development.
- The sharpest annual moves came in 2022 and 2025: Research & Development jumped 247.15% in 2022, then retreated 22.63% in 2025.
- A 5-year view of Research & Development shows it stood at $450612.0 in 2022, then declined by 3.95% to $432818.0 in 2023, then fell by 9.74% to $390658.0 in 2024, then declined by 4.26% to $374012.0 in 2025, then decreased by 6.5% to $349707.0 in 2026.
- Business Quant data shows BIAF's Research & Development at $349707.0 in Q1 2026, $374012.0 in Q4 2025, and $330589.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 30,529.42 Bn | 30,528.96 Bn | 1.11 Bn | 96.00 Mn |
| 2 | Thermo Fisher Scientific | 183.75 Bn | 180.50 Bn | 7.74 Bn | 336.00 Mn |
| 3 | Danaher | 133.13 Bn | 127.43 Bn | 3.59 Bn | 387.00 Mn |
| 4 | Idexx Laboratories | 46.14 Bn | 45.94 Bn | 722.74 Mn | 65.79 Mn |
| 5 | Agilent Technologies | 38.20 Bn | 36.39 Bn | 990.00 Mn | 126.00 Mn |
| 6 | Natera | 31.50 Bn | 30.40 Bn | 696.04 Mn | 210.70 Mn |
| 7 | Iqvia Holdings | 31.34 Bn | 29.36 Bn | 1.36 Bn | - |
| 8 | Illumina | 24.51 Bn | 23.36 Bn | 721.00 Mn | 240.00 Mn |
| 9 | Mettler Toledo International | 23.53 Bn | 23.47 Bn | 555.82 Mn | 51.28 Mn |
| 10 | bioAffinity Technologies | 2.08 Mn | -1.02 Mn | - | 349,707.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 349,707.00 |
| Dec 31, 2025 | 374,012.00 |
| Sep 30, 2025 | 330,589.00 |
| Jun 30, 2025 | 311,372.00 |
| Mar 31, 2025 | 367,386.00 |
| Dec 31, 2024 | 390,658.00 |
| Sep 30, 2024 | 274,497.00 |
| Jun 30, 2024 | 402,433.00 |
| Mar 31, 2024 | 393,639.00 |
| Dec 31, 2023 | 432,818.00 |
| Sep 30, 2023 | 330,376.00 |
| Jun 30, 2023 | 335,125.00 |
| Mar 31, 2023 | 369,617.00 |
| Dec 31, 2022 | 450,612.00 |
| Sep 30, 2022 | 319,744.00 |
| Jun 30, 2022 | 248,419.00 |
| Mar 31, 2022 | 279,848.00 |
| Dec 31, 2021 | 129,802.00 |
| Sep 30, 2021 | 330,772.00 |